Do you want to read an article? Please log in or register.
Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study
Am J Respir Crit Care Med.
Oelsner EC, Balte PP, Grams ME, Cassano PA, Jacobs DR, Barr RG, Burkart KM, Kalhan R, Kronmal R, Loehr LR, O'Connor GT, Schwartz JE, Shlipak M, Tracy RP, Tsai MY, White W, Yende S
doi: 10.1164/rccm.
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/
RECOMMENDED
Lung Cancer
Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study
Eur Respir J.
Raymakers AJN, Sadatsafavi M, Sin DD, FitzGerald JM, Marra CA, Lynd LD
doi: 10.1183/13993003.
COPD
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet Respir Med.
GBD 2015 Chronic Respiratory Disease Collaborators
doi: 10.1016/S2213-2600
Chronic Obstructive Pulmonary Disease and the Risk of Stroke
Ann Am Thorac Soc.
Morgan AD, Sharma C, Rothnie KJ, Potts J, Smeeth L, Quint JK
doi: 10.1513/AnnalsATS.
RECOMMENDED
Pulmonary Fibrosis
Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Duckworth A, Gibbons MA, Allen RJ, Almond H, Beaumont RN, Wood AR, Lunnon K, Lindsay MA, Wain LV, Tyrrell J, Scotton CJ
doi: 10.1016/S2213-2600(20)30364-7.Visit the original publication at ncbi.nlm.nih.gov
COMMENTED
COPD
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS
Ann Am Thorac Soc.
Ghosh S, Anderson WH, Putcha N, Han MK, Curtis JL, Criner GJ, Dransfield MT, Barr RG, Krishnan JA, Lazarus SC, Cooper CB, Paine R 3rd, Peters SP, Hansel NN, Martinez FJ, Drummond MB, Current and former investigators of the SPIROMICS sites and reading centers
doi: 10.1513/AnnalsATS.201804-283OC.
COPDLung Cancer
Features of Chronic Obstructive Pulmonary Disease as Predictors of Lung Cancer
Chest.
Carr LL, Jacobson S, Lynch DA, Foreman MG, Flenaugh EL, Hersh CP, Sciurba FC, Wilson DO, Sieren JC, Mulhall P, Kim V, Kinsey CM, Bowler RP
doi: 10.1016/j.chest.2018.01.049.
COPD
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study
Respiration.
Rodrigo-Troyano A, Melo V, Marcos PJ, Laserna E, Peiro M, Suarez-Cuartin G, Perea L, Feliu A, Plaza V, Faverio P, Restrepo MI, Anzueto A, Sibila O
doi: 10.1159/000490190.